Academia

"Research, teaching, innovation"

Prof. Dworakowska has an extensive research portfolio in endocrinology, endocrine oncology, endocrine cardiology and general medicine.She is a Professor at Medical University of Gdansk, Poland and an Honorary Senior Clinical Lecturer in Cancer Studies at Kings College London. She received a title of Professor in Medicine from a Polish President Mr Duda and Polish Government in 2019. In 2020 she has been nominated as a member of Polish Academy of Science. She has published a significant amount of original research papers, reviews and book chapters. She teaches and provides lectures internationally as well as runs international, translational and multidisciplinary research in endocrinology.

Recent publications

Thyroid

Dorota DworakowskaAshley B Grossman. Thyroid Disease in the Time of COVID-19. Endocrine. 2020 Jun 7;1-4. doi: 10.1007/s12020-020-02364-8. Online ahead of print.

Hypertension

Dorota Dworakowska, Ashley B Grossman. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic. J Physio Pharm. 2020, 71,2 7;1-4. doi: 10.26402/jpp.2020.2.xx. in press

Recent presentations

Selected books chapters:

Dworakowska D, Grossman AB. Introduction to endocrinology for nuclear medicine specialists. In Nuclear endocrinologyprinting pending, 2020

Dworakowska D, Grossman AB (July 2014) The Molecular Genetics of Corticotroph Tumours. In: eLS 2014, John Wiley & Sons Ltd: Chichester 

Dworakowska D, Aylwin A. Pituitary disease in pregnancy. In Neurology and Pregnancy: Clinical Management, Informa Healthcare, 2012

Grant P, Dworakowska D. Psychological aspects of erectile dysfunction. In Erectile dysfunction, Nova Biomedical, 2012

 

Selected papers:

Dworakowska D, Grossman AB. Colonic Cancer and Acromegaly. Front Endocrinol. 2019;10:390

Dworakowska D, Grossman AB. Aggressive and malignant pituitary tumours: state-of-the-artEndocr Relat Cancer. 2018;25:R559–R575

Dworakowska DDrabarek AWenzel I, et al. Adrenocortical cancer (ACC) – literature overview and own experience. Endokrynol Pol. 2014;65(6):492-512

Dworakowska D, Grossman AB. The molecular pathogenesis of pituitary tumours: implications for clinical management. Minerva Endocrinol. 2012; 37:157-72

Whitelaw B, Dworakowska D, Thomas N, et al. Temozolomide in the management of dopamine resistant prolactinomas. Clin Endocrinol 2012; 76:877-86

Dworakowska D, Korbonits M, Aylwin S, McGregor A, Grossman AB. Pathology of pituitary ademonas from clinical perspective. Frontiers in Bioscience, Front Biosci 2011; 3: 105-16

Dworakowska D, Gueorguiev M, Kelly P, et al. 15 Years Experience Of Repeated Colonoscopic Screening Of Patients With Acromegaly Identifies Those at Risk of New Colonic Neoplasia And Allows For Effective Screening Guidelines. Eur J Endocrinol. 2010 161: 1-9

Dworakowska D, Wlodek E, Leontiou CA, et al. Activation of B-RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer 2009; 16: 1329-38

Dworakowska D, Grossman ABThe Pathophysiology of Pituitary Adenomas. Best Pract Res Clin Endocrinol Metab 2009; 23: 525-41

Dworakowska D, Grossman AB. Are neuroendocrine tumors a feature of tuberous sclerosis? Endocr Relat Cancer 2009; 16:45-58.